0001638599-17-000126.txt : 20170130
0001638599-17-000126.hdr.sgml : 20170130
20170130213959
ACCESSION NUMBER: 0001638599-17-000126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170126
FILED AS OF DATE: 20170130
DATE AS OF CHANGE: 20170130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lipocine Inc.
CENTRAL INDEX KEY: 0001535955
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990370688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 ARAPEEN DRIVE, SUITE 202
CITY: SALT LAKE CITY
STATE: X1
ZIP: 84108
BUSINESS PHONE: 801 994 7383
MAIL ADDRESS:
STREET 1: 675 ARAPEEN DRIVE, SUITE 202
CITY: SALT LAKE CITY
STATE: X1
ZIP: 84108
FORMER COMPANY:
FORMER CONFORMED NAME: MARATHON BAR CORP
DATE OF NAME CHANGE: 20111130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ono Richard Dana
CENTRAL INDEX KEY: 0001595989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36357
FILM NUMBER: 17559244
MAIL ADDRESS:
STREET 1: 18 SPRING ROAD
CITY: CONCORD
STATE: MA
ZIP: 01742
4
1
doc4_4501.xml
PRIMARY DOCUMENT
X0306
4
2017-01-26
0
0001535955
Lipocine Inc.
LPCN
0001595989
Ono Richard Dana
C/O 675 ARAPEEN DRIVE
SUITE 202
SALT LAKE CITY
UT
84108
1
0
0
0
Restricted Stock Unit
0
2017-01-26
4
A
0
7000
0
A
2017-12-31
2027-01-25
Common stock
7000
7000
D
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit
Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021.
/s/Richard Dana Ono
2017-01-30